CD28 — Drug Target

All drugs that target CD28 — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

anti-CD28 monoclonal antibody · Monoclonal antibody · monoclonal antibody

Phase 3 pipeline (1)

• AML Y mg · Celltrion · anti-CD28 monoclonal antibody · Oncology
  AML Y mg is an anti-CD28 monoclonal antibody that inhibits T-cell activation.

Phase 2 pipeline (2)

• CNTO 1275 · Centocor, Inc. · Monoclonal antibody · Immunology
  CNTO 1275 is a fully human monoclonal antibody that targets the CD28 receptor.
• CERC-301 · Avalo Therapeutics, Inc. · monoclonal antibody · Autoimmune diseases, Oncology
  CERC-301 is a monoclonal antibody targeting CD28 to modulate T-cell activation.